Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion

Cancer Genome Atlas Research Network, None, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia The New England Journal of Medicine. ,vol. 368, pp. 2059- 2074 ,(2013) , 10.1056/NEJMOA1301689

Andreas D. Ørskov, Marianne B. Treppendahl, Anni Skovbo, Mette S. Holm, Lone S. Friis, Marianne Hokland, Kirsten Grønbæk, Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation Oncotarget. ,vol. 6, pp. 9612- 9626 ,(2015) , 10.18632/ONCOTARGET.3324

Howard A. Burris, III, Eric Raymond, Ahmad Awada, John G. Kuhn, Timothy J. O‘Rourke, James Brentzel, William Lynch, Shang-Ying P. King, Thomas D. Brown, Daniel D. Von Hoff, Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies Investigational New Drugs. ,vol. 16, pp. 19- 27 ,(1998) , 10.1023/A:1016066529642

Martin D. Abeloff, Louise B. Grochow, Dennis A. Noe, Alexander Hantel, Eric K. Rowinsky, Huey-Shin L. Shen, Barbara V. Clarke, William B. McGuire, David B. Adams, Ross C. Donehower, David S. Ettinger, Phase I and pharmacokinetic study of brequinar sodium (NSC 368390). Cancer Research. ,vol. 50, pp. 4595- 4599 ,(1990)

Hervé Dombret, John F. Seymour, Aleksandra Butrym, Agnieszka Wierzbowska, Dominik Selleslag, Jun Ho Jang, Rajat Kumar, James Cavenagh, Andre C. Schuh, Anna Candoni, Christian Récher, Irwindeep Sandhu, Teresa Bernal del Castillo, Haifa Kathrin Al-Ali, Giovanni Martinelli, Jose Falantes, Richard Noppeney, Richard M. Stone, Mark D. Minden, Heidi McIntyre, Steve Songer, Lela M. Lucy, C. L. Beach, Hartmut Döhner, International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts Blood. ,vol. 126, pp. 291- 299 ,(2015) , 10.1182/BLOOD-2015-01-621664

CharlesB. Pratt, JosephA. Sinkule, Erlinda Etcubanas, EdwinC. Douglass, DeborahB. Crom, Kyung Choi, Loraine Avery, Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumors. Investigational New Drugs. ,vol. 4, pp. 149- 153 ,(1986) , 10.1007/BF00194594

Christopher A. Lipinski, Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies. ,vol. 1, pp. 337- 341 ,(2004) , 10.1016/J.DDTEC.2004.11.007

H Yang, C Bueso-Ramos, C DiNardo, M R Estecio, M Davanlou, Q-R Geng, Z Fang, M Nguyen, S Pierce, Y Wei, S Parmar, J Cortes, H Kantarjian, G Garcia-Manero, Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents Leukemia. ,vol. 28, pp. 1280- 1288 ,(2014) , 10.1038/LEU.2013.355

Richard A. Friesner, Jay L. Banks, Robert B. Murphy, Thomas A. Halgren, Jasna J. Klicic, Daniel T. Mainz, Matthew P. Repasky, Eric H. Knoll, Mee Shelley, Jason K. Perry, David E. Shaw, Perry Francis, Peter S. Shenkin, Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry. ,vol. 47, pp. 1739- 1749 ,(2004) , 10.1021/JM0306430

Guifang Jia, Ye Fu, Chuan He, Reversible RNA adenosine methylation in biological regulation Trends in Genetics. ,vol. 29, pp. 108- 115 ,(2013) , 10.1016/J.TIG.2012.11.003